PMID: 9181527May 1, 1997Paper

Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial

Journal of Viral Hepatitis
A BellobuonoG Ideo

Abstract

Interferon-alpha (IFN-alpha) induces sustained remission of chronic hepatitis C in approximately 25% of patients. In patients who are non-responders to the first course of therapy, retreatment with IFN-alpha is of limited efficacy. Ribavirin has also been used to treat chronic hepatitis C, but it induces only a transient response. In this study, we evaluated the efficacy of ribavirin and IFN-alpha combination therapy for IFN-alpha resistant chronic hepatitis C. Twenty-four IFN-alpha non-responders and 24 relapsers were randomized to receive either ribavirin (1000 mg per day) together with IFN-alpha (3-6 million units (MU) thrice weekly) or the same dose of IFN-alpha alone, for 6 months. Both at the end of treatment and 6 months later, normal transaminase levels were more common in the patients receiving combination therapy than in the group receiving IFN-alpha alone: 17 (70.8%) vs seven (29.2%) patients (P = 0.009) and six (25%) vs one (4.2%) patient (P = 0.034), respectively. At the end of treatment and 6 months later, serum HCV RNA was no longer detectable in eight (33.3%) and five (20.8%) patients in the combination therapy group and in six (25%) and one (4.2%) patient in the IFN-alpha therapy group, respectively. Three pati...Continue Reading

Citations

Aug 10, 2000·Journal of Medical Virology·C ArgentiniM Rapicetta
Dec 1, 1996·Digestive Diseases and Sciences·S W SchalmO Weiland
Oct 17, 1998·Clinical Reviews in Allergy & Immunology·A Della RossaS Bombardieri
Sep 12, 2000·Current Gastroenterology Reports·G L Davis
Nov 26, 2003·Antiviral Research·Jesús MedinaRicardo Moreno-Otero
Mar 23, 2000·Journal of Hepatology·N Boyer, P Marcellin
Jan 6, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BresciA Capria
May 11, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M PuotiG Carosi
Apr 12, 2000·Alimentary Pharmacology & Therapeutics·O Lo IaconoR Moreno-Otero
Jun 26, 2001·Alimentary Pharmacology & Therapeutics·V Di MarcoA Craxì
Jun 10, 2000·Journal of Viral Hepatitis·L A KondiliA Mele
Nov 26, 1999·Journal of Gastroenterology and Hepatology·R PellicanoA Ponzetto
Aug 2, 2000·Journal of Gastroenterology and Hepatology·W C Chow
Jun 20, 2001·Gut·J C BoothUNKNOWN Thr Royal College of Physicians of London and the British Society of Gastroenterology
Jun 8, 2013·World Journal of Gastroenterology : WJG·Qing-Lei ZengFu-Sheng Wang
Jun 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A GervaisP Marcellin
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S PolC Bréchot
Mar 3, 2005·Alimentary Pharmacology & Therapeutics·B J VeldtS W Schalm
Jan 15, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Eiichi TomitaMitsuru Seishima
Nov 14, 2001·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·E B DevineS D Sullivan
Jul 20, 2007·The Cochrane Database of Systematic Reviews·L L GluudC Gluud
Nov 11, 2005·The American Journal of Gastroenterology·Ira M JacobsonBrian R Edlin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.